Clinical Trials List
2022-12-01 - 2026-06-30
Phase I
Not yet recruiting4
Recruiting1
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
CMIC Asia-Pacific
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chong-Jen Yu 無
- CHAO-CHI HO CHAO-CHI HO 無
- 梁逸歆 無
- 蔡子修 無
- 許嘉林 無
- 吳尚俊 無
- 陳國興 無
- James Chih-Hsin Yang 無
- JIN-YUAN SHIH 無
- 楊景堯 無
- Jih-Hsiang Lee 無
- YU-YUN SHAO 無
- 廖斌志 無
- 徐偉勛 無
- 廖唯昱 無
- YEN-TING LIN 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Shang-Yin Wu 未分科
- 黃盈慈 未分科
- Chun-Hui Lee 未分科
- Jui-Hung Tsai 未分科
- Chien-Chung Lin 未分科
- Wu-Chou Su 未分科
- Shang-Hung Chen 未分科
- Po-Lan Su 未分科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
222 participants
